Holen Sie sich die Stockscreener-App
1.32
0.76%
0.01
Handel nachbörslich:
1.32
Medicinova Inc Aktie (MNOV) Neueste Nachrichten
FY2028 EPS Estimates for MediciNova Lowered by HC Wainwright - MarketBeat
MediciNova Inc (NASDAQ: MNOV) Share Price, MNOV Stock News, MNOV Share Price & Updates - Kalkine
MediciNova (MNOV) Reports Q2 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
MediciNova (NASDAQ:MNOV) Announces Quarterly Earnings Results - MarketBeat
MediciNova Inc reports results for the quarter ended June 30Earnings Summary - TradingView
MediciNova: Q2 Earnings Snapshot - aol.com
MNOV: Q2 2026 revenue grew and net loss narrowed, with cash reserves supporting operations into 2027 - TradingView
MNOV Q2'26 Earnings: EPS estimate is (0.06) USD - TradingView
MediciNova Inc (MNOV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MediciNova Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
MNOV Q2'26 Earnings: revenue estimate is 75.00K USD - TradingView
MediciNova (MNOV) Projected to Release Earnings on Thursday - MarketBeat
Price to book forward of MediciNova, Inc. – NASDAQ:MNOV - tradingview.com
MediciNova, Inc. Revenue Breakdown – NASDAQ:MNOV - TradingView
MediciNova Inc (MNOV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MediciNova Inc (MNOV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MediciNova Inc (MNOV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
MediciNova Inc (MNOV) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
MediciNova Inc (MNOV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to EBIT forward of MediciNova, Inc. – NASDAQ:MNOV - TradingView
Price to sales forward of MediciNova, Inc. – NASDAQ:MNOV - TradingView
Enterprise value to EBIT forward of MediciNova, Inc. – TSE:4875 - TradingView
MediciNova stock trades steady as investors weigh recent losses and pipeline progress - Ad-hoc-news.de
Price to sales forward of MediciNova, Inc. – TSE:4875 - TradingView
MediciNova stock trades steady as pipeline progress contrasts with lower recent revenues - Ad-hoc-news.de
Analysts Offer Insights on Healthcare Companies: Medicinova (MNOV), Legend Biotech (LEGN) and AngioDynamics (ANGO) - The Globe and Mail
MediciNova, Inc. (NASDAQ:MNOV) Sees Significant Increase in Short Interest - MarketBeat
H.C. Wainwright Maintains MediciNova(MNOV.US) With Buy Rating, Maintains Target Price $10 - Moomoo
MediciNova reaches 200-patient enrollment in ALS study - Investing.com
MediciNova reaches 200-patient enrollment in ALS study By Investing.com - Investing.com Nigeria
ALS patients ineligible for trials join MediciNova's 200-person study - Stock Titan
MNOV Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Progress ContinuesOperating Income Trends - DonanımHaber
D Boral Capital maintains MediciNova (MNOV) buy recommendation - MSN
MediciNova Inc outlines its biotech pipeline as investors watch MN-166 progress - Ad-hoc-news.de
Medicinova Inc (MNOV) Holds Steady Near Support After Modest AdvanceFactor Crowding - dars.gov.et
Medicinova Inc (MNOV) Surges 7.6% as Biotech Stock Tests Resistance at $1.49Opening Range Breakout - dars.gov.et
Enterprise value to revenue forward of MediciNova, Inc. – TSE:4875 - TradingView
Price to earnings forward of MediciNova, Inc. – TSE:4875 - TradingView
Enterprise value to EBITDA forward of MediciNova, Inc. – NASDAQ:MNOV - TradingView
MediciNova completes patient visits in phase 2 NAFLD trial - Investing.com
MediciNova CEO Provides Shareholder Update - GlobeNewswire
Medicinova Inc (MNOV) Edges Higher: Biotech Stock Tests Resistance After Modest GainPrice Target - dars.gov.et
Medicinova Inc (MNOV) Edges Higher as Stock Holds Above Key SupportIV Spike - dars.gov.et
Medicinova Inc (MNOV) Edges Higher, Holds Above Key Support Amid Low-Volume TradeBPI Reversal - dars.gov.et
MNOV Q1 2026 Earnings: EPS Beat Drives Positive Stock Reaction Despite No RevenueQuarterly Profit Report - dars.gov.et
MediciNova, Inc. Actuals & Estimates (NASDAQ:MNOV) - TradingView
Form 4 MediciNova Inc For: 25 June By Investing.com - Investing.com Nigeria
MediciNova (MNOV) director awarded 44,500 stock options - Stock Titan
MediciNova (MNOV) director Nicole Lemerond receives 44,500 stock options grant - Stock Titan
MediciNova (MNOV) director receives grant of 44,500 stock options - Stock Titan
MediciNova Shareholders Reject Proposal to Increase Authorized Stock - TipRanks
MediciNova (MNOV) 2026 annual meeting voting recap and totals - Stock Titan
Medicinova Inc (MNOV) Holds Near Support Amid Modest DeclineStop Loss Guidance - dars.gov.et
MediciNova Inc (MNOV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MediciNova Inc (MNOV) Institutional Confidence - TradingKey
1.80%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):